HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two cases of intranasal naloxone self-administration in opioid overdose.

AbstractBACKGROUND:
Overdose is a leading cause of death for former prisoners, exacting its greatest toll during the first 2 weeks post release. Protective effects have been observed with training individuals at high risk of overdose and prescribing them naloxone, an opioid antagonist that reverses the effects of the opioid-induced respiratory depression that causes death.
CASES:
The authors report 2 people with opiate use histories who self-administered intranasal naloxone to treat their own heroin overdoses following release from prison. Patient A is a 34-year-old male, who reported having experienced an overdose on heroin the day after he was released from incarceration. Patient B is a 29-year-old female, who reported an overdose on her first injection of heroin, 17 days post release from incarceration. Both patients self-administered the medication but were assisted at some point during the injury by a witness whom they had personally instructed in how to prepare and administer the medication. Neither patient experienced withdrawal symptoms following exposure to naloxone.
DISCUSSION:
Self-administration of naloxone should not be a goal of overdose death prevention training. A safer, more reliable approach is to prescribe naloxone to at-risk patients and train and also equip members of their household and social or drug-using networks in overdose prevention and response.
AuthorsTraci C Green, Madeline Ray, Sarah E Bowman, Michelle McKenzie, Josiah D Rich
JournalSubstance abuse (Subst Abus) Vol. 35 Issue 2 Pg. 129-32 ( 2014) ISSN: 1547-0164 [Electronic] United States
PMID24821348 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Narcotic Antagonists
  • Narcotics
  • Naloxone
  • Heroin
Topics
  • Administration, Intranasal
  • Adult
  • Drug Overdose (drug therapy, prevention & control)
  • Female
  • Heroin (antagonists & inhibitors, toxicity)
  • Humans
  • Male
  • Naloxone (administration & dosage)
  • Narcotic Antagonists (administration & dosage)
  • Narcotics (toxicity)
  • Self Medication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: